Biology without walls: The novel endocrinology of bone

Annual Review of Physiology

Volumn 74, Issue , 2012, Pages 87-105

  Karsenty, Gerard ^a   Oury, Franck ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Bone mass accrual; Energy metabolism; Osteocalcin; Reproduction; Serotonin

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; LEPTIN; MELANOCORTIN 4 RECEPTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN HYDROXYLASE;

ADIPOCYTE; ANOREXIA NERVOSA; ARTICLE; BONE; BONE MASS; BONE TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; DEPRESSION; ENDOCRINOLOGY; ENERGY EXPENDITURE; ENERGY METABOLISM; FOOD INTAKE; GENETICS; HUMAN; HYPERPHAGIA; HYPOTHALAMUS; MOOD DISORDER; NERVE CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPRODUCTION; SIDE EFFECT;

ADIPOCYTES; ANIMALS; BONE AND BONES; BONE REMODELING; BRAIN; ENDOCRINE SYSTEM; ENERGY METABOLISM; FEMALE; FERTILITY; GASTROINTESTINAL TRACT; HORMONES; HUMANS; MICE; OSTEOBLASTS; OSTEOCALCIN; PANCREAS; PREGNANCY;

EID: 84857279874     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-020911-153233     Document Type: Article

References (112)

1. Bernard C. 1865. An Introduction to the Study of Experimental Medicine. Paris: Flamarion
2. CannonWB. 1929. Organization for physiological homeostasis. Physiol. Rev. 9:399-431
3. Cannon WB. 1932. The Wisdom of the Body. New York: Norton.
4. Henderson LJ. 1913. The Fitness of the Environment: An Inquiry into the Biological Significance of the Properties of Matter. New York: Macmillan
5. Karsenty G. 2006. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab. 4:341-48 (Pubitemid 44645074)
6. Rodan GA, Martin TJ. 2000. Therapeutic approaches to bone diseases. Science 289:1508-14
7. Teitelbaum SL. 2000. Osteoclasts, integrins, and osteoporosis. J. Bone Miner. Metab. 18:344-49
8. Harada S, Rodan GA. 2003. Control of osteoblast function and regulation of bonemass. Nature 423:349-55 (Pubitemid 40852710)
9. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, et al. 2000. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197-207 (Pubitemid 30064908)
10. Reid IR. 2002. Relationships among body mass, its components, and bone. Bone 31:547-55 (Pubitemid 35449695)
11. Rigotti NA, Nussbaum SR, Herzog DB, Neer RM. 1984. Osteoporosis in women with anorexia nervosa. N. Engl. J. Med. 311:1601-6 (Pubitemid 15175200)
12. Wolfert A, Mehler PS. 2002. Osteoporosis: prevention and treatment in anorexia nervosa. Eat. Weight Disord. 7:72-81
13. Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW. 2007. Relationship of obesity with osteoporosis. J. Clin. Endocrinol. Metab. 92:1640-46 (Pubitemid 46997165)
14. Zipfel S, Seibel MJ, Lowe B, Beumont PJ, Kasperk C, Herzog W. 2001. Osteoporosis in eating disorders: a follow-up study of patients with anorexia and bulimia nervosa. J. Clin. Endocrinol. Metab. 86:5227-33 (Pubitemid 33070240)
15. Khosla S. 2010. Update on estrogens and the skeleton. J. Clin. Endocrinol. Metab. 95:3569-77
16. Riggs BL, OFallon WM, Muhs J, OConnor MK, Kumar R, Melton LJ 3rd. 1998. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J. Bone Miner. Res. 13:168-74 (Pubitemid 28082372)
17. Ahima RS. 2004. Body fat, leptin, and hypothalamic amenorrhea. N. Engl. J. Med. 351:959-62 (Pubitemid 39166258)
18. Ahima RS, Saper CB, Flier JS, Elmquist JK. 2000. Leptin regulation of neuroendocrine systems. Front. Neuroendocrinol. 21:263-307 (Pubitemid 30495784)
19. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, et al. 1998. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398-401 (Pubitemid 28168737)
20. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, et al. 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514-20 (Pubitemid 40477060)
21. Spiegelman BM, Flier JS. 2001. Obesity and the regulation of energy balance. Cell 104:531-43 (Pubitemid 32201948)
22. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, et al. 2002. Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-17 (Pubitemid 35345151)
23. Doyon C, Drouin G, Trudeau VL, Moon TW. 2001. Molecular evolution of leptin. Gen. Comp. Endocrinol. 124:188-98 (Pubitemid 33065590)
24. Huising MO, Geven EJ, Kruiswijk CP, Nabuurs SB, Stolte EH, et al. 2006. Increased leptin expression in common carp (Cyprinus carpio) after food intake but not after fasting or feeding to satiation. Endocrinology 147:5786-97 (Pubitemid 44833495)
25. Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, et al. 2004. Serum leptin level is a regulator of bone mass. Proc. Natl. Acad. Sci. USA 101:3258-63 (Pubitemid 38327768)
26. Karsenty G, Oury F. 2010. The central regulation of bone mass, the first link between bone remodeling and energy metabolism. J. Clin. Endocrinol. Metab. 95:4795-801
27. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. 2005. Themolecular clock mediates leptin-regulated bone formation. Cell 122:803-15 (Pubitemid 41242643)
28. Karsenty G, Kronenberg HM, Settembre C. 2009. Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 25:629-48
29. Lowrey PL, Takahashi JS. 2004. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu. Rev. Genomics Hum. Genet. 5:407-41 (Pubitemid 39362752)
30. Morse D, Sassone-Corsi P. 2002. Time after time: inputs to and outputs from the mammalian circadian oscillators. Trends Neurosci. 25:632-37 (Pubitemid 35356511)
31. Okamura H, Miyake S, Sumi Y, Yamaguchi S, Yasui A, et al. 1999. Photic induction of mPer1 and mPer2 in Cry-deficient mice lacking a biological clock. Science 286:2531-34
32. Perreau-Lenz S, Pevet P, Buijs RM, Kalsbeek A. 2004. The biological clock: the bodyguard of temporal homeostasis. Chronobiol. Int. 21:1-25 (Pubitemid 38529226)
33. Teitelbaum SL, Ross FP. 2003. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4:638-49 (Pubitemid 36917505)
34. Zheng B, Albrecht U, Kaasik K, Sage M, Lu W, et al. 2001. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 105:683-94 (Pubitemid 32524120)
35. Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC. 2004. β-Adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J. Bone Miner. Res. 19:19-24 (Pubitemid 41295133)
36. Rejnmark L, Vestergaard P, Mosekilde L. 2006. Treatment with β-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J. Hypertens. 24:581-89 (Pubitemid 43261923)
37. Schlienger RG, Kraenzlin ME, Jick SS, Meier CR. 2004. Use of β-blockers and risk of fractures. JAMA 292:1326-32
38. Turker S, Karatosun V, Gunal I. 2006. β-Blockers increase bone mineral density. Clin. Orthop. Relat. Res. 443:73-74 (Pubitemid 44324936)
39. Bonnet N, Benhamou CL, Malaval L, Goncalves C, Vico L, et al. 2008. Low dose β-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions. J. Cell Physiol. 217:819-27
40. Asnicar MA, Smith DP, Yang DD, Heiman ML, Fox N, et al. 2001. Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology 142:4394-400 (Pubitemid 32907069)
41. Elias CF, Lee C, Kelly J, Aschkenasi C, Ahima RS, et al. 1998. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21:1375-85 (Pubitemid 29022539)
42. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, et al. 1998. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393:72-76 (Pubitemid 28240256)
43. Ahn JD, Dubern B, Lubrano-Berthelier C, Clement K, Karsenty G. 2006. Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency. Endocrinology 147:3196-202 (Pubitemid 43901110)
44. Abizaid A, Gao Q, Horvath TL. 2006. Thoughts for food: brain mechanisms and peripheral energy balance. Neuron 51(6):691-702 (Pubitemid 44374909)
45. Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, et al. 2007. Central control of bone remodeling by neuromedin U. Nat. Med. 13(10):1234-40 (Pubitemid 47530632)
46. Hetherington AW, Ranson SW. 1940. Hypothalamic lesions and adipocity in the rat. Anat. Rec. 78:149-72
47. Hetherington AW, Ranson SW. 1942. The relation of various hypothalamic lesions to adiposity in the rat. J. Comp. Neurol. 76:475-99
48. Brobeck JR. 1946. Mechanisms of the development of obesity in animals with hypothalamic lesions. Physiol. Rev. 26:541-59
49. Anand BK, Brobeck JR. 1951. Localization of a feeding center in the hypothalamus of the rat. Proc. Soc. Exp. Biol. Med. 77:323-24
50. Debons AF, Silver L, Cronkite EP, Johnson HA, Brecher G, et al. 1962. Localization of gold in mouse brain in relation to gold thioglucose obesity. Am. J. Physiol. 202:743-50
51. Olney JW. 1969. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164:719-21
52. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, et al. 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-95 (Pubitemid 26060722)
53. Fei H, Okano HJ, Li C, Lee GH, Zhao C, et al. 1997. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc. Natl. Acad. Sci. USA 94:7001-5 (Pubitemid 27281980)
54. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, et al. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-35 (Pubitemid 26053452)
55. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, et al. 1995. Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263-71 (Pubitemid 26007816)
56. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, et al. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-32 (Pubitemid 24365442)
57. Balthasar N, Coppari R, McMinn J, Liu SM, Lee CE, et al. 2004. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42:983-91 (Pubitemid 38798236)
58. Yadav VK, Oury F, Suda N, Liu ZW, Gao XB, et al. 2009. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138:976-89
59. Haney EM, Chan BK, Diem SJ, Ensrud KE, Cauley JA, et al. 2007. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch. Intern. Med. 167:1246-51 (Pubitemid 46998495)
60. Kaye W, Gendall K, Strober M. 1998. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biol. Psychiatry 44:825-38 (Pubitemid 28520221)
61. Laekeman G, Zwaenepoel L, Reyntens J, de Vos M, CasteelsM. 2008. Osteoporosis after combined use of a neuroleptic and antidepressants. Pharm. World Sci. 30:613-16
62. Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, et al. 2007. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch. Intern. Med. 167:188-94 (Pubitemid 46148067)
63. Ziere G, Dieleman JP, van der Cammen TJ, Hofman A, Pols HA, Stricker BH. 2008. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J. Clin. Psychopharmacol. 28:411-17
64. Gershon MD, Tack J. 2007. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132:397-414 (Pubitemid 46127672)
65. Mann JJ, McBride PA, Brown RP, Linnoila M, Leon AC, et al. 1992. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch. Gen. Psychiatry 49:442-46
66. Walther DJ, Peter J-U, Bashammakh S, Hörtnagl H, Voits M, et al. 2003. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299:76 (Pubitemid 36042402)
67. Yadav VK, Oury F, Tanaka K, Thomas T, Wang Y, et al. 2011. Leptin-dependent serotonin control of appetite: temporal specificity, transcriptional regulation, and therapeutic implications. J. Exp. Med. 208:41-52
68. Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, et al. 2008. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135:825-37
69. Oury F, Yadav VK, Wang Y, Zhou B, Liu XS, et al. 2010. CREB mediates brain serotonin regulation of bone mass through its expression in ventromedial hypothalamic neurons. Genes Dev. 24:2330-42
70. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, et al. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346:1513-21 (Pubitemid 34755690)
71. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, et al. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-23 (Pubitemid 33152786)
72. Yadav VK, Balaji S, Suresh PS, Liu XS, Lu X, et al. 2010. Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat. Med. 16:308-12
73. Lee K, Nichols J, Smith A. 1996. Identification of a developmentally regulated protein tyrosine phosphatase in embryonic stem cells that is a marker of pluripotential epiblast and early mesoderm. Mech. Dev. 59:153-64 (Pubitemid 26379336)
74. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, et al. 2007. Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-69 (Pubitemid 47208519)
75. Mauro LJ, Olmsted EA, Skrobacz BM, Mourey RJ, Davis AR, Dixon JE. 1994. Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. J. Biol. Chem. 269:30659-67 (Pubitemid 24376554)
76. Dacquin R, Mee PJ, Kawaguchi J, Olmsted-Davis EA, Gallagher JA, et al. 2004. Knock-in of nuclear localised β-galactosidase reveals that the tyrosine phosphatase Ptprv is specifically expressed in cells of the bone collar. Dev. Dyn. 229:826-34 (Pubitemid 38429111)
77. Ferron M, Hinoi E, Karsenty G, Ducy P. 2008. Osteocalcin differentially regulates βcell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. USA 105:5266-70 (Pubitemid 351738545)
78. Hauschka PV, Lian JB, Cole DE, Gundberg CM. 1989. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol. Rev. 69:990-1047 (Pubitemid 19184853)
79. Ducy P, Desbois C, Boyce B, Pinero G, Story B, et al. 1996. Increased bone formation in osteocalcindeficient mice. Nature 382:448-52 (Pubitemid 26264860)
80. Kajimura D, Hinoi E, Ferron M, Kode A, Riley KJ, et al. 2011. Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual. J. Exp. Med. 388:34-42
81. Yang X, Karsenty G. 2004. ATF4, the osteoblast accumulation of which is determined posttranslationally, can induce osteoblast-specific gene expression in non-osteoblastic cells. J. Biol. Chem. 279:47109-14 (Pubitemid 39518367)
82. Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, et al. 2004. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117:387-98 (Pubitemid 38534544)
83. Yoshizawa T, Hinoi E, Jung DY, Kajimura D, Ferron M, et al. 2009. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J. Clin. Investig. 119:2807-17
84. Aonuma H, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y. 2009. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption. Tohoku J. Exp. Med. 218:201-5
85. Fernandez-Real JM, Izquierdo M, Ortega F, Gorostiaga E, Gomez-Ambrosi J, et al. 2009. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J. Clin. Endocrinol. Metab. 94:237-45
86. Hwang YC, Jeong IK, Ahn KJ, Chung HY. 2009. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced β-cell function in middle-aged male subjects. Diabetes Metab. Res. Rev. 25:768-72
87. Im JA, Yu BP, Jeon JY, Kim SH. 2008. Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin. Chim. Acta 396:66-69
88. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, et al. 2009. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 94:45-49
89. Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, Tivesten A, et al. 2009. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J. Bone Miner. Res. 24:785-91
90. Levinger I, Zebaze R, Jerums G, Hare DL, Selig S, Seeman E. 2011. The effect of acute exercise on undercarboxylated osteocalcin in obese men. Osteoporos. Int. 2(5):1621-66
91. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. 2009. Association between serum osteocalcin and markers of metabolic phenotype. J. Clin. Endocrinol. Metab. 94:827-32
92. Winhofer Y, Handisurya A, Tura A, Bittighofer C, Klein K, et al. 2010. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care 33:139-43
93. Yeap BB, Chubb SA, Flicker L, McCaul KA, Ebeling PR, et al. 2010. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur. J. Endocrinol. 163:265-72
94. Delibegovic M, Bence KK, Mody N, Hong EG, Ko HJ, et al. 2007. Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B. Mol. Cell. Biol. 27:7727-34 (Pubitemid 350033677)
95. Delibegovic M, Zimmer D, Kauffman C, Rak K, Hong EG, et al. 2009. Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes 58:590-99
96. Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, et al. 2002. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell 3:25-38 (Pubitemid 34778393)
97. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, et al. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559-69 (Pubitemid 128379082)
98. Konner AC, Janoschek R, Plum L, Jordan SD, Rother E, et al. 2007. Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab. 5:438-49 (Pubitemid 46825497)
99. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. 1999. Tissue-specific knockout of the insulin receptor in pancreatic βcells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329-39 (Pubitemid 29077587)
100. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, et al. 2000. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6:87-97
101. Kong YY, Boyle WJ, Penninger JM. 1999. Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. Immunol. Cell Biol. 77:188-93 (Pubitemid 29167060)
102. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, et al. 2010. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142:296-308
103. Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, et al. 2010. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142:309-19
104. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, et al. 1998. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. USA 95:13453-58 (Pubitemid 28522993)
105. Scimeca JC, Franchi A, Trojani C, Parrinello H, Grosgeorge J, et al. 2000. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 26:207-13 (Pubitemid 30101642)
106. Hinoi E, Gao N, Jung DY, Yadav V, Yoshizawa T, et al. 2008. The sympathetic tone mediates leptins inhibition of insulin secretion by modulating osteocalcin bioactivity. J. Cell Biol. 183:1235-42
107. Rached MT, Kode A, Silva BC, Jung DY, Gray S, et al. 2010. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J. Clin. Investig. 120:357-68
108. Rached MT, Kode A, Xu L, Yoshikawa Y, Paik JH, et al. 2010. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 11:147-60
109. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, et al. 2007. Estrogen prevents bone loss via estrogen receptor αand induction of Fas ligand in osteoclasts. Cell 130:811-23 (Pubitemid 47332572)
110. Manolagas SC, Kousteni S, Jilka RL. 2002. Sex steroids and bone. Recent Prog. Horm. Res. 57:385-409
111. Oury F, Sumara G, Sumara O, Ferron M, Chang H, et al. 2011. Endocrine regulation of male fertility by the skeleton. Cell 144:796-809
112. Pi M, Chen L, Huang MZ, Zhu W, Ringhofer B, et al. 2008. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS ONE 3:e3858